Tekla Financial Statements From 2010 to 2026

HQL Stock  USD 16.60  0.26  1.54%   
Tekla Life's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Tekla Life's valuation are provided below:
Gross Profit
1.9 M
Profit Margin
44.1574
Market Capitalization
491.3 M
Enterprise Value Revenue
5.6877
Revenue
1.9 M
There are over one hundred nineteen available fundamental trend indicators for Tekla Life Sciences, which can be analyzed over time and compared to other ratios. We recommend to double-check Tekla Life's current fundamental drivers against the all of the trends between 2010 and 2026. The value of Market Cap is estimated to slide to about 267.6 M. The Enterprise Value is projected to slide to about 268.5 M

Tekla Life Total Revenue

104.31 Million

Check Tekla Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tekla Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 M, Interest Expense of 0.0 or Total Revenue of 104.3 M, as well as many indicators such as Price To Sales Ratio of 5.33, Dividend Yield of 0.1 or PTB Ratio of 0.7. Tekla financial statements analysis is a perfect complement when working with Tekla Life Valuation or Volatility modules.
  
Build AI portfolio with Tekla Stock
Check out the analysis of Tekla Life Correlation against competitors.

Tekla Life Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets350 M592.7 M416 M
Slightly volatile
Total Current Liabilities787.6 K829 K2.2 M
Very volatile
Total Stockholder Equity346.5 M590.7 M412.8 M
Slightly volatile
Accounts Payable787.6 K829 K1.2 M
Very volatile
Non Current Assets Total345.9 M591.2 M411.1 M
Slightly volatile
Cash And Short Term Investments82.5 K86.9 K1.9 M
Pretty Stable
Common Stock Total Equity260.9 K274.7 K134.2 M
Slightly volatile
Common Stock Shares Outstanding20.1 M33.2 M22 M
Slightly volatile
Liabilities And Stockholders Equity350 M592.7 M416 M
Slightly volatile
Total Liabilities3.4 MM3.2 M
Pretty Stable
Total Current Assets1.4 M1.4 M5.4 M
Slightly volatile
Common Stock253.1 K266.4 K134.3 M
Slightly volatile
Net Receivables2.5 M1.3 M2.9 M
Pretty Stable
Net Tangible Assets449.7 M457.6 M430 M
Pretty Stable
Long Term Investments456.8 M591.2 M445.4 M
Slightly volatile
Other Liabilities13.1 K16 K13.8 K
Slightly volatile
Non Current Liabilities Total1.1 M1.2 MM
Very volatile
Capital Stock253.1 K266.4 K177.5 M
Slightly volatile
Short and Long Term Debt Total13.4 M12.8 M4.2 M
Slightly volatile
Capital Surpluse400.8 M428.4 M367.9 M
Slightly volatile
Current Deferred Revenue4.1 M4.6 MM
Slightly volatile

Tekla Life Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2.1 M2.2 MM
Slightly volatile
Other Operating Expenses864.8 K910.3 K18.3 M
Slightly volatile
Cost Of RevenueMM4.6 M
Slightly volatile
Total Operating Expenses864.8 K910.3 K18.7 M
Slightly volatile
Selling General Administrative811.9 K854.6 K2.2 M
Slightly volatile
Interest Income299.1 K314.9 K28.1 M
Slightly volatile
Research Development0.490.511.7453
Slightly volatile
Net Interest Income303.9 K402.3 K206.5 K
Slightly volatile

Tekla Life Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow0.860.9202.9 K
Pretty Stable
Total Cashflows From Investing Activities13.5 M12.9 M13.4 M
Slightly volatile
Other Cashflows From Investing Activities13.5 M12.9 M13.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio5.335.61129
Slightly volatile
Dividend Yield0.10.09910.0822
Slightly volatile
PTB Ratio0.70.830.8826
Pretty Stable
Days Sales Outstanding5.255.53497
Slightly volatile
Book Value Per Share14.2914.7419.3542
Slightly volatile
Average Payables978K851.5 K
Pretty Stable
PB Ratio0.70.830.8826
Pretty Stable
Inventory Turnover0.360.410.4424
Slightly volatile
Days Of Inventory On Hand649730797
Slightly volatile
Payables Turnover0.930.9822.2449
Slightly volatile
Sales General And Administrative To Revenue0.00940.00991.4807
Slightly volatile
Average Inventory5.6 M7.9 M6.8 M
Slightly volatile
Cash Per Share0.580.550.2284
Slightly volatile
Days Payables Outstanding296386159
Slightly volatile
Current Ratio2.631.564.151
Slightly volatile
Tangible Book Value Per Share14.2914.7419.3542
Slightly volatile
Receivables Turnover64.968.31313
Very volatile
Shareholders Equity Per Share14.2914.7419.3529
Slightly volatile
Debt To Equity0.02630.02510.0098
Slightly volatile
Average Receivables747.9 K787.3 K1.3 M
Slightly volatile
Revenue Per Share2.922.781.315
Slightly volatile
Interest Debt Per Share0.470.51.5733
Slightly volatile
Debt To Assets0.02530.02410.0094
Slightly volatile
Graham Number26.3730.1235.6507
Slightly volatile
Operating Cycle5.255.53545
Slightly volatile
Price Book Value Ratio0.70.830.8826
Pretty Stable
Days Of Payables Outstanding296386159
Slightly volatile
Company Equity Multiplier0.810.90.9899
Slightly volatile
Total Debt To Capitalization0.02560.02440.0095
Slightly volatile
Debt Equity Ratio0.02630.02510.0098
Slightly volatile
Net Income Per E B T0.80.90.9822
Slightly volatile
Days Of Inventory Outstanding649730797
Slightly volatile
Days Of Sales Outstanding5.255.53497
Slightly volatile
Price To Book Ratio0.70.830.8826
Pretty Stable
Debt Ratio0.02530.02410.0094
Slightly volatile
Price Sales Ratio5.335.61129
Slightly volatile
Asset Turnover0.160.150.0706
Slightly volatile
Price Fair Value0.70.830.8826
Pretty Stable

Tekla Life Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap267.6 M380.8 M369.7 M
Pretty Stable
Enterprise Value268.5 M380.8 M370.6 M
Pretty Stable

Tekla Fundamental Market Drivers

About Tekla Life Financial Statements

Tekla Life investors utilize fundamental indicators, such as revenue or net income, to predict how Tekla Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue4.6 M4.1 M
Total Revenue99.3 M104.3 M
Cost Of RevenueMM
Sales General And Administrative To Revenue 0.01  0.01 
Revenue Per Share 2.78  2.92 
Ebit Per Revenue 0.89  0.94 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Tekla Life Sciences is a strong investment it is important to analyze Tekla Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tekla Life's future performance. For an informed investment choice regarding Tekla Stock, refer to the following important reports:
Check out the analysis of Tekla Life Correlation against competitors.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.594
Dividend Share
1.82
Earnings Share
2.79
Revenue Per Share
0.065
Quarterly Revenue Growth
(0.70)
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.